Erratum: Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline (J Clin Endo Metab (2016) 101: 11 (3922-3937) DOI: 10.1210/jc.2016-2534)

A. L. Peters, A. J. Ahmann, T. Battelino, A. Evert, I. B. Hirsch, M. H. Murad, W. E. Winter, H. Wolpert

Research output: Contribution to journalComment/debatepeer-review

Abstract

Endocrine Society guidelines can be retired for any of the following reasons: the guideline as a whole is sufficiently out of date that it is no longer relevant to clinical practice; one or more of the guideline recommendations contain important inaccuracies or omissions that, if followed precisely, could lead to substandard patient care or potential harm; or the guideline has been replaced by a more recent publication.

Original languageEnglish (US)
Pages (from-to)E201
JournalJournal of Clinical Endocrinology and Metabolism
Volume108
Issue number5
DOIs
StatePublished - May 1 2023

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Biochemistry
  • Endocrinology
  • Clinical Biochemistry
  • Biochemistry, medical

Fingerprint

Dive into the research topics of 'Erratum: Diabetes Technology—Continuous Subcutaneous Insulin Infusion Therapy and Continuous Glucose Monitoring in Adults: An Endocrine Society Clinical Practice Guideline (J Clin Endo Metab (2016) 101: 11 (3922-3937) DOI: 10.1210/jc.2016-2534)'. Together they form a unique fingerprint.

Cite this